NADSYN1-C11ORF34 Fusion FISH Probe
The NADSYN1-C11ORF34 Fusion FISH Probe is used to confirm a fusion of the NADSYN1 and C11ORF34 genes. The fusion of the NADSYN1 and C11ORF34 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NADSYN1-C11ORF34-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-C11ORF34-20-AQAQ | 20 (40 μL) | 200 μL |
|
NADSYN1 Gene Summary
Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).[supplied by OMIM, Apr 2004]
Gene Name: NAD Synthetase 1
Chromosome: CHR11: 71164216 -71212581
Locus: 11q13.4
Gene Diseases
The NADSYN1 C11ORF34 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|